Category Over-the-Counter Drugs

Axxess Pharma Receives Health Canada Approval to Sell High Potency Omega-3 Fish Oil Supplement Throughout Canada

Nov19

TORONTO, ON (Marketwired) 11/19/14 Axxess Pharma Inc. (PINKSHEETS: AXXE), a specialty pharmaceutical and nutritional supplements company, through its wholly owned subsidiary, AllStar Health Brands Inc., is pleased to announce they have now received Health Canada approval to sell their high potency Omega-3 fish oil supplement throughout Canada. The Omega-3 fish oil will be sold under […]

PURAMED BIOSCIENCE INC.

Nov19

The following discussion and analysis of the Company’s financial condition andplan of operations should be read and considered along with its condensedfinancial statements and related notes included in this Quarterly Report on Form10-Q. Various statements have been made in this Quarterly Report on Form 10-Qthat may constitute "forward-looking statements." Forward-looking statements mayalso be made in […]

Federal Regulators Announce the Recall of Mayhem Dietary Supplements After Laboratory Testing Reveals Undeclared Drugs, Parker Waichman LLP Comments

Nov19

Port Washington, New York (PRWEB) November 19, 2014 Parker Waichman LLP, a national law firm representing patients injured by drugs and medical devices comments on a recall of Mayhem dietary supplements, produced by Chaotic Labz of Atkins, Arkansas. The recalled supplements were recalled after distribution nationwide to online stores and nutritional supplement sellers. The recall […]

Bayer acquires OTC drug firm Dihon for $586 million [China Daily: Africa Weekly]

Nov18

Germany-based drugmaker Bayer AG said it has completed the acquisition of privately held Dihon Pharmaceutical Group Co Ltd in Kunming, capital of Yunnan province, for 3.6 billion yuan ($586 million), which will help it become the world’s largest non-prescription medicine group.Bayer will hold 100 percent of Dihon, which specializes in over-the-counter skin products and herbal […]

Bayer acquires OTC drug firm Dihon for $586 million [China Daily: US Edition]

Nov18

Germany-based drugmaker Bayer AG said it has completed the acquisition of privately held Dihon Pharmaceutical Group Co Ltd in Kunming, capital of Yunnan province, for 3.6 billion yuan ($586 million), which will help it become the world’s largest non-prescription medicine group.Bayer will hold 100 percent of Dihon, which specializes in over-the-counter skin products and herbal […]

Bayer acquires OTC drug firm Dihon for $586 million [China Daily: Hong Kong Edition]

Nov18

Germany-based drugmaker Bayer AG said it has completed the acquisition of privately held Dihon Pharmaceutical Group Co Ltd in Kunming, capital of Yunnan province, for 3.6 billion yuan ($586 million), which will help it become the world’s largest non-prescription medicine group.Bayer will hold 100 percent of Dihon, which specializes in over-the-counter skin products and herbal […]

Jeffrey D. DeCarlo Law, P.A., Comments On Study Claiming Dangerous Prescription Drug Ingredients Found In Dietary Supplements

Nov17

Miami, FL (PRWEB) November 17, 2014 Ingredients for potentially dangerous prescription drugs have been found in over-the-counter dietary supplements, even though these ingredients were recalled for safety reasons years ago, according to a recent study that came as no surprise to drug injury lawyer Jeffrey D. DeCarlo of the Law Office of Jeffrey D. DeCarlo, […]

Purdue Pharma L.P. Names Gail Cawkwell, MD, PhD, Vice President of Medical Affairs

Nov17

STAMFORD, Conn., Nov. 17, 2014 /PRNewswire/ Purdue Pharma L.P. today announced that Gail Cawkwell, MD, PhD, former Vice President in the Medicines Development Group at Pfizer, has joined the company as Vice President of Medical Affairs.“Gail brings to Purdue strong credentials and broad and relevant skills in all aspects of Medical Affairs, including drug development […]

Actavis To Acquire Allergan In $66 Bln Deal

Nov17

DUBLIN (dpa-AFX) – Specialty pharmaceutical company Actavis plc (ACT) agreed Monday to acquire botox maker Allergan, Inc. (AGN) in a cash and stock deal valued at about $219 per share or $66 billion.The deal will enable Allergan to fend off a hostile takeover bid from Canadian drug maker Valeant Pharmaceuticals, Inc. (VRX.TO, VRX), which is […]

New retrospective data showed empagliflozin reduced A1C, body weight and markers of abdominal fat in adults with type 2 diabetes

Nov17

RIDGEFIELD, Conn. and INDIANAPOLIS, Nov. 17, 2014 /PRNewswire/ Empagliflozin tablets reduced hemoglobin A1C (a measure of average blood sugar over the past two to three months), body weight and several markers of abdominal fat in adults with type 2 diabetes (T2D), according to a new retrospective analysis of clinical trial data presented on behalf of […]